Genpact Limited Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Genpact Limited (G) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price of $0.00 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice · last filed 2026-08-07
- Genpact Limited share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2026-03-31 was $0.00.
- Genpact Limited share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2025-03-31 was $0.00.
- Genpact Limited share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.00.
- Genpact Limited share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2023-03-31 was $0.00.
- Genpact Limited share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Genpact Limited share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2024 was $45.19, a 2.84% increase from fiscal 2023.
- Genpact Limited share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2023 was $43.94.
- Genpact Limited share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2022 was $0.00.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-11 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-12 | |||
| 2024-12-31 | $45.19 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $45.19 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-09 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-10 | |||
| 2023-12-31 | $43.94 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $43.94 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | $43.94 10-Q · filed 2023-08-09 | |||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-03-03 | |||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | |||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 | |||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 | |||
| 2015-12-31 | $14.32 8-K · filed 2018-06-04 | |||
| 2015-09-30 | $14.32 10-Q · filed 2015-11-06 | |||
| 2015-06-30 | $0.00 10-Q · filed 2015-08-07 | |||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-08 | |||
| 2014-12-31 | $12.32 10-K · filed 2017-03-01 | |||
| 2014-09-30 | $12.32 10-Q · filed 2014-11-07 | |||
| 2014-06-30 | $12.32 10-Q · filed 2014-08-08 | |||
| 2014-03-31 | $12.32 10-Q · filed 2014-05-09 | |||
| 2013-12-31 | $13.26 10-K · filed 2016-02-26 | |||
| 2013-09-30 | $13.79 10-Q · filed 2013-11-08 | |||
| 2013-06-30 | $13.79 10-Q · filed 2013-08-09 | |||
| 2012-12-31 | $15.46 10-K · filed 2015-02-27 | |||
| 2012-09-30 | $15.23 10-Q · filed 2012-11-09 | |||
| 2012-06-30 | $15.32 10-Q · filed 2012-08-09 | |||
| 2011-12-31 | $15.54 10-K · filed 2014-02-28 | |||
| 2010-12-31 | $14.95 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FTI CONSULTING, INC (FCN) | United States | $3.602B | 16.33 |
| EXPONENT INC (EXPO) | United States | $3.065B | 26.46 |
| Huron Consulting Group Inc. (HURN) | United States | $2.557B | 20.80 |
| Booz Allen Hamilton Holding Corp (BAH) | United States | $8.878B | 9.38 |
| Astrana Health, Inc. (ASTH) | United States | $1.921B | 63.77 |
| ICF International, Inc. (ICFI) | United States | $1.490B | 14.74 |
| Bowman Consulting Group Ltd. (BWMN) | United States | $0.738B | 68.09 |
| Onterris, Inc. (ONT) | United States | $0.590B | -63.69 |
| Public Policy Holding Company, Inc. (PPHC) | United States | $0.347B | |
| Aeries Technology, Inc. (AERT) | Cayman Islands | $0.336B | -0.00 |